|
|
||||||||
The Journal of Immunology, Vol 146, Issue 9 3056-3062, Copyright © 1991 by American Association of Immunologists
ARTICLES |
AJ Ritchie, DR Johnson, BM Ewenstein and JS Pober
Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115.
We have investigated whether TNF-induced changes in human endothelial cell (EC) surface Ag expression are mediated by protein kinase C (PKC). This suggestion arose from the observations that PMA, a potent PKC activator, can mimic TNF by inducing expression of endothelial leukocyte adhesion molecule 1, intercellular adhesion molecule 1 (ICAM- 1), and class I MHC molecules on human EC. However, in contrast to the actions of PMA, TNF neither causes membrane translocation of PKC nor induces the phosphorylation of the myristoylated alanine-rich C kinase substrate, two measures of PKC activation. Moreover, the PKC inhibitor staurosporine can block PMA-induced endothelial leukocyte adhesion molecule 1 expression at 4 h, but does not inhibit the actions of TNF. At 24 h, staurosporine itself induces intercellular adhesion molecule 1 and class I MHC, and acts additively with TNF. Twenty four hour treatment with PMA causes loss of PKC. We propose that at 24 h, staurosporine and PMA share a mechanism of action, namely diminution of PKC activity. However, 24 h treatment with TNF does not reduce the amount of PKC nor does it prevent activation of PKC by PMA. We conclude that TNF effects in EC are not mediated by PKC activation or inactivation.
This article has been cited by other articles:
![]() |
K. Javaid, A. Rahman, K. N. Anwar, R. S. Frey, R. D. Minshall, and A. B. Malik Tumor Necrosis Factor-{alpha} Induces Early-Onset Endothelial Adhesivity by Protein Kinase C{zeta}-Dependent Activation of Intercellular Adhesion Molecule-1 Circ. Res., May 30, 2003; 92(10): 1089 - 1097. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Oshima, K. P. Pavlick, F. S. Laroux, S. K. Verma, P. Jordan, M. B. Grisham, L. Williams, and J. S. Alexander Regulation and distribution of MAdCAM-1 in endothelial cells in vitro Am J Physiol Cell Physiol, October 1, 2001; 281(4): C1096 - C1105. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hoshi, M. Goto, N. Koyama, K.-i. Nomoto, and H. Tanaka Regulation of Vascular Smooth Muscle Cell Proliferation by Nuclear Factor-kappa B and Its Inhibitor, I-kappa B J. Biol. Chem., January 14, 2000; 275(2): 883 - 889. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zidovetzki, J.-L. Wang, J. A. Kim, P. Chen, M. Fisher, and F. M. Hofman Endothelin-1 Enhances Plasminogen Activator Inhibitor-1 Production by Human Brain Endothelial Cells via Protein Kinase C-Dependent Pathway Arterioscler. Thromb. Vasc. Biol., July 1, 1999; 19(7): 1768 - 1775. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Terry, J. A. Clikeman, J. R. Hoidal, and K. S. Callahan TNF-alpha and IL-1alpha induce heme oxygenase-1 via protein kinase C, Ca2+, and phospholipase A2 in endothelial cells Am J Physiol Heart Circ Physiol, May 1, 1999; 276(5): H1493 - H1501. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tamaru and S. Narumi E-selectin Gene Expression Is Induced Synergistically with the Coexistence of Activated Classic Protein Kinase C and Signals Elicited by Interleukin-1beta but Not Tumor Necrosis Factor-alpha J. Biol. Chem., February 5, 1999; 274(6): 3753 - 3763. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. May, C. P. D. Wheeler-Jones, R. A. Houliston, and J. D. Pearson Activation of p42mapk in human umbilical vein endothelial cells by interleukin-1alpha and tumor necrosis factor-alpha Am J Physiol Cell Physiol, March 1, 1998; 274(3): C789 - C798. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Mason, H. Yarwood, K. Sugars, and D. O. Haskard Human umbilical vein and dermal microvascular endothelial cells show heterogeneity in response to PKC activation Am J Physiol Cell Physiol, October 1, 1997; 273(4): C1233 - C1240. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Deguchi, H. Takeya, H. Wada, E. C. Gabazza, N. Hayashi, H. Urano, and K. Suzuki Dilazep, an Antiplatelet Agent, Inhibits Tissue Factor Expression in Endothelial Cells and Monocytes Blood, September 15, 1997; 90(6): 2345 - 2356. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Slowik, L. G. De Luca, W. Min, and J. S. Pober Ceramide Is Not a Signal for Tumor Necrosis Factor–Induced Gene Expression but Does Cause Programmed Cell Death in Human Vascular Endothelial Cells Circ. Res., October 1, 1996; 79(4): 736 - 747. [Abstract] [Full Text] |
||||
![]() |
D. R. Johnson, I. Douglas, A. Jahnke, S. Ghosh, and J. S. Pober A Sustained Reduction in Ikappa B-beta May Contribute to Persistent NF-kappa B Activation in Human Endothelial Cells J. Biol. Chem., July 5, 1996; 271(27): 16317 - 16322. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Greenfield, M. C. Horowitz, and S. A. Lavish Stimulation by Parathyroid Hormone of Interleukin-6 and Leukemia Inhibitory Factor Expression in Osteoblasts Is an Immediate-early Gene Response Induced by cAMP Signal Transduction J. Biol. Chem., May 3, 1996; 271(18): 10984 - 10989. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ochi, N. Kume, E. Nishi, and T. Kita Elevated Levels of cAMP Inhibit Protein Kinase C– Independent Mechanisms of Endothelial Platelet-Derived Growth Factor–B Chain and Intercellular Adhesion Molecule-1 Gene Induction by Lysophosphatidylcholine Circ. Res., September 1, 1995; 77(3): 530 - 535. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |